Kaolinite in pharmaceutics and biomedicine

被引:167
作者
Awad, Mahmoud E. [1 ,2 ,3 ]
Lopez-Galindo, Alberto [2 ]
Setti, Massimo [4 ]
El-Rahmany, Mahmoud M. [1 ]
Viseras Iborra, Cesar [2 ,3 ]
机构
[1] Al Azhar Univ Cairo, Dept Geol, Fac Sci, Nasr City 11884, Egypt
[2] UGR, CSIC, Inst Andaluz Ciencias Tierra, Ave Palmeras 4, Granada 18100, Spain
[3] Univ Granada, Dept Farm & Tecnol Farmaceut, E-18071 Granada, Spain
[4] Univ Pavia, Dipartimento Sci Terra & Ambiente, Via Ferrata 1, I-27100 Pavia, Italy
关键词
Kaolinite; Excipient; Active pharmaceutical ingredient; Drug carrier; Cosmetic; Pelotherapy; New health care uses; DOSE DRUG RIBOFLAVINE; CLAY-MINERALS; IN-VITRO; DECREASED BIOAVAILABILITY; ANTIBACTERIAL ACTIVITY; ADSORBENT ANTACIDS; INVITRO ADSORPTION; PROTECTIVE CREAMS; HEALTH-CARE; RELEASE;
D O I
10.1016/j.ijpharm.2017.09.056
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Kaolinite Al2Si2O5(OH)(4) is an abundant and inexpensive geomaterial regarded as one of the most common clay minerals in the earth's crust and the most widespread phase among the other kaolin polymorphs (halloysite, dickite and nacrite). Structurally, it is a hydrous aluminum phyllosilicate member belonging to the dioctahedral 1:1 kaolin mineral group. The particle size of the pseudohexagonal kaolinite platelets is normally< 2 mu m (if compared to a human red blood cell of a typical diameter 6.2-8.2 mu m or to a virus particle of about 50 nm diameter). The kaolinite platelets, either stacked together with a common booklet-like shape in a highly ordered structure (well crystallized) or disordered structure (poorly crystallized), consist of layers considered as a strong dipole of hydrophobic siloxane surface dominated by negative charges, and the other hydrophilic aluminol surface carries positive charges. Kaolinite has been used in many pharmaceutical applications as excipient or active ingredient, because it exhibits excellent physical, chemical and surface physicochemical properties. In addition to their classical pharmaceutical uses, kaolinite and its derivatives have been recently considered as a promising material in many biomedical innovation areas such as drug, protein and gene delivery based on the high interaction capacities with organic and biochemical molecules, bioadhesion and cellular uptake. Pharmaceutical kaolin grades are considerably demanded for usage as excipient in formulations of solid and semi-solid dosage forms. The most important functionalities of kaolin used as excipient are reported as diluent, binder, disintegrant, pelletizing and granulating, amorphizing, particle film coating, emulsifying and suspending agent. Because of its uninjured bioactivity, kaolinite has been also used as active agent for treatment of some common diseases. It can be topically administered as hemostatic agent, dermatological protector, anti-inflammatory agent and in pelotherapy, or orally as gastrointestinal protector, and antibacterial, antiviral, detoxification or antidiarrheal agent. With these premises, the future of kaolinite in health-care uses is strongly interesting, especially in the development of pharmaceutical and cosmetic industries. In biomedicinal investigations, it can be considered as a promising natural geomaterial for designing new derivatives that can contribute in the trials of discovering new therapeutic systems and treatment pathways of global challenge diseases such as cancer, viruses, antibiotic resistant bacteria, alzheimer, chronic skeletomuscular and geriatric diseases.
引用
收藏
页码:34 / 48
页数:15
相关论文
共 249 条
[1]  
Abdel-Khalek N.A., 2014, J MIN WORLD EXPRESS, V3, P46, DOI DOI 10.14355/MWE.2014.03.007
[2]  
Agrawal R., 2011, International Journal of Pharmaceutical Frontier Research, P65
[3]  
al Gohary O M, 1997, Pharm Acta Helv, V72, P11
[4]   Field effects of kaolin particle film formulation against major cotton lepidopteran pests in North Benin, West Africa [J].
Alavo, T. B. C. ;
Yarou, B. B. ;
Atachi, P. .
INTERNATIONAL JOURNAL OF PEST MANAGEMENT, 2010, 56 (04) :287-290
[5]   INFLUENCE OF KAOLIN-PECTIN SUSPENSION ON DIGOXIN BIOAVAILABILITY [J].
ALBERT, KS ;
AYRES, JW ;
DISANTO, AR ;
WEIDLER, DJ ;
SAKMAR, E ;
HALLMARK, MR ;
STOLL, RG ;
DESANTE, KA ;
WAGNER, JG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (11) :1582-1586
[6]   PHARMACOKINETIC EVALUATION OF A DRUG INTERACTION BETWEEN KAOLIN-PECTIN AND CLINDAMYCIN [J].
ALBERT, KS ;
DESANTE, KA ;
WELCH, RD ;
DISANTO, AR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (11) :1579-1582
[7]   Determination and characterization of metronidazole-kaolin interaction [J].
Aleanizy, Fadilah Sfouq ;
Alqahtani, Fulwah ;
Al Gohary, Omaimah ;
El Tahir, Eram ;
Al Shalabi, Rania .
SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (02) :167-176
[8]  
ALESTIG K, 1979, PRACTITIONER, V222, P859
[9]   AN INTERPRETATION OF THE SEDIMENTATION BEHAVIOR OF PHARMACEUTICAL KAOLIN AND OTHER KAOLIN PREPARATIONS IN AQUEOUS ENVIRONMENTS [J].
ALEXANDER, KS ;
AZIZI, J ;
DOLLIMORE, D ;
PATEL, FA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (14-16) :2559-2582
[10]  
ALGOHARY O, 1988, PHARM ACTA HELV, V63, P13